Using a threshold for positivity of 20 % (previously defined as the most optimal threshold for positivity to predict prognosis in stage II CRC patients using RET methylation [27]), we detected RET promoter CpG island methylation in 32 out of 240 (13.3 %) patient samples. The gene discussed is RET; the disease is colorectal carcinoma.